CD22 and acute lymphoblastic leukemia: Satake and co-workers discovered that the conjugation of superparamagnetic iron oxide nanoparticles (SPIO NPs) with anti-CD22 mAb enhances the delivery efficacy of siRNA therapy in acute lymphoblastic leukemia (ALL) 178.